

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.30837506 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.30837506 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.11551570 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.11551570 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.64410671 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.47035426 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.22577426 |
| 8 | sulfur amino acid catabolic process (GO:0000098) | 5.18753546 |
| 9 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.16015592 |
| 10 | cysteine metabolic process (GO:0006534) | 5.12675843 |
| 11 | glyoxylate metabolic process (GO:0046487) | 4.92630873 |
| 12 | high-density lipoprotein particle remodeling (GO:0034375) | 4.78305253 |
| 13 | urea cycle (GO:0000050) | 4.77695433 |
| 14 | urea metabolic process (GO:0019627) | 4.77695433 |
| 15 | bile acid biosynthetic process (GO:0006699) | 4.76715186 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.74627383 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 4.74627383 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.74627383 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 4.70949094 |
| 20 | kynurenine metabolic process (GO:0070189) | 4.69906194 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.58991185 |
| 22 | tryptophan metabolic process (GO:0006568) | 4.49208593 |
| 23 | protein carboxylation (GO:0018214) | 4.48329196 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.48329196 |
| 25 | regulation of apoptotic cell clearance (GO:2000425) | 4.42078085 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 4.42026940 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.41348082 |
| 28 | complement activation, alternative pathway (GO:0006957) | 4.40270016 |
| 29 | intestinal cholesterol absorption (GO:0030299) | 4.39368787 |
| 30 | reverse cholesterol transport (GO:0043691) | 4.39215994 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.38064909 |
| 32 | plasma lipoprotein particle clearance (GO:0034381) | 4.37195397 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 4.33199106 |
| 34 | lysine metabolic process (GO:0006553) | 4.32560736 |
| 35 | lysine catabolic process (GO:0006554) | 4.32560736 |
| 36 | ethanol oxidation (GO:0006069) | 4.27165789 |
| 37 | regulation of plasminogen activation (GO:0010755) | 4.26251939 |
| 38 | cellular glucuronidation (GO:0052695) | 4.24157833 |
| 39 | bile acid metabolic process (GO:0008206) | 4.19369050 |
| 40 | blood coagulation, intrinsic pathway (GO:0007597) | 4.15348415 |
| 41 | proline metabolic process (GO:0006560) | 4.14277107 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.13982618 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.13982618 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.13982618 |
| 45 | homocysteine metabolic process (GO:0050667) | 4.12790221 |
| 46 | serine family amino acid catabolic process (GO:0009071) | 4.11610216 |
| 47 | phospholipid efflux (GO:0033700) | 4.10593001 |
| 48 | regulation of protein activation cascade (GO:2000257) | 4.08309902 |
| 49 | drug catabolic process (GO:0042737) | 4.07097202 |
| 50 | omega-hydroxylase P450 pathway (GO:0097267) | 4.06872197 |
| 51 | * amino-acid betaine metabolic process (GO:0006577) | 4.06130777 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.03132290 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.03132290 |
| 54 | negative regulation of sterol transport (GO:0032372) | 3.97872032 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 3.97872032 |
| 56 | uronic acid metabolic process (GO:0006063) | 3.96544550 |
| 57 | glucuronate metabolic process (GO:0019585) | 3.96544550 |
| 58 | tyrosine metabolic process (GO:0006570) | 3.95335591 |
| 59 | aromatic amino acid family metabolic process (GO:0009072) | 3.93920528 |
| 60 | protein-lipid complex subunit organization (GO:0071825) | 3.89469089 |
| 61 | xenobiotic catabolic process (GO:0042178) | 3.85158387 |
| 62 | regulation of cholesterol homeostasis (GO:2000188) | 3.84449091 |
| 63 | regulation of complement activation (GO:0030449) | 3.81923121 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 3.81216655 |
| 65 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.81036044 |
| 66 | negative regulation of protein activation cascade (GO:2000258) | 3.77124704 |
| 67 | benzene-containing compound metabolic process (GO:0042537) | 3.74626942 |
| 68 | cholesterol efflux (GO:0033344) | 3.74586218 |
| 69 | valine metabolic process (GO:0006573) | 3.73282403 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 3.72608183 |
| 71 | epoxygenase P450 pathway (GO:0019373) | 3.71201558 |
| 72 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.70263953 |
| 73 | fatty acid beta-oxidation (GO:0006635) | 3.69204541 |
| 74 | positive regulation of lipid catabolic process (GO:0050996) | 3.65743183 |
| 75 | response to nitrosative stress (GO:0051409) | 3.64869210 |
| 76 | protein activation cascade (GO:0072376) | 3.64513321 |
| 77 | exogenous drug catabolic process (GO:0042738) | 3.63766405 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 3.63478434 |
| 79 | cellular amino acid catabolic process (GO:0009063) | 3.63061209 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 3.62553009 |
| 81 | low-density lipoprotein particle remodeling (GO:0034374) | 3.62430300 |
| 82 | * fatty acid oxidation (GO:0019395) | 3.61430405 |
| 83 | negative regulation of hemostasis (GO:1900047) | 3.61377275 |
| 84 | negative regulation of blood coagulation (GO:0030195) | 3.61377275 |
| 85 | short-chain fatty acid metabolic process (GO:0046459) | 3.61285736 |
| 86 | aldehyde catabolic process (GO:0046185) | 3.59860362 |
| 87 | drug metabolic process (GO:0017144) | 3.55463527 |
| 88 | * lipid oxidation (GO:0034440) | 3.55424623 |
| 89 | glutamate metabolic process (GO:0006536) | 3.54110592 |
| 90 | 2-oxoglutarate metabolic process (GO:0006103) | 3.53286785 |
| 91 | drug transmembrane transport (GO:0006855) | 3.52324631 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.51369151 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.51369151 |
| 94 | monocarboxylic acid catabolic process (GO:0072329) | 3.51252775 |
| 95 | complement activation, classical pathway (GO:0006958) | 3.49998975 |
| 96 | phospholipid homeostasis (GO:0055091) | 3.49925281 |
| 97 | regulation of humoral immune response (GO:0002920) | 3.48797337 |
| 98 | low-density lipoprotein particle clearance (GO:0034383) | 3.48715805 |
| 99 | bile acid and bile salt transport (GO:0015721) | 3.47793863 |
| 100 | fatty acid catabolic process (GO:0009062) | 3.47759859 |
| 101 | serine family amino acid metabolic process (GO:0009069) | 3.45916040 |
| 102 | primary alcohol catabolic process (GO:0034310) | 3.44841653 |
| 103 | organic acid catabolic process (GO:0016054) | 3.43108019 |
| 104 | carboxylic acid catabolic process (GO:0046395) | 3.43108019 |
| 105 | cholesterol homeostasis (GO:0042632) | 3.42566586 |
| 106 | coenzyme catabolic process (GO:0009109) | 3.41288770 |
| 107 | fibrinolysis (GO:0042730) | 3.39775757 |
| 108 | positive regulation of blood coagulation (GO:0030194) | 3.38953699 |
| 109 | positive regulation of hemostasis (GO:1900048) | 3.38953699 |
| 110 | proline biosynthetic process (GO:0006561) | 3.38575601 |
| 111 | acetyl-CoA metabolic process (GO:0006084) | 3.38289310 |
| 112 | sterol homeostasis (GO:0055092) | 3.38221227 |
| 113 | complement activation (GO:0006956) | 3.36424730 |
| 114 | lipoprotein metabolic process (GO:0042157) | 3.34472579 |
| 115 | ethanol metabolic process (GO:0006067) | 3.33071628 |
| 116 | indolalkylamine metabolic process (GO:0006586) | 3.32447880 |
| 117 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.31506635 |
| 118 | arginine metabolic process (GO:0006525) | 3.31498377 |
| 119 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.31177722 |
| 120 | protein-lipid complex assembly (GO:0065005) | 3.31141270 |
| 121 | acute-phase response (GO:0006953) | 3.30791635 |
| 122 | regulation of bile acid biosynthetic process (GO:0070857) | 3.29212765 |
| 123 | negative regulation of coagulation (GO:0050819) | 3.29196161 |
| 124 | plasma lipoprotein particle organization (GO:0071827) | 3.29183104 |
| 125 | glucose 6-phosphate metabolic process (GO:0051156) | 3.27545286 |
| 126 | intestinal absorption (GO:0050892) | 3.26264527 |
| 127 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.24525092 |
| 128 | negative regulation of lipid transport (GO:0032369) | 3.23625041 |
| 129 | progesterone metabolic process (GO:0042448) | 3.23120036 |
| 130 | negative regulation of complement activation (GO:0045916) | 3.21399428 |
| 131 | positive regulation of coagulation (GO:0050820) | 3.21384197 |
| 132 | * regulation of cholesterol biosynthetic process (GO:0045540) | 3.19641284 |
| 133 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.19537552 |
| 134 | negative regulation of wound healing (GO:0061045) | 3.19379248 |
| 135 | positive regulation of extracellular matrix organization (GO:1903055) | 3.17471459 |
| 136 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.12129558 |
| 137 | polyketide metabolic process (GO:0030638) | 3.10650156 |
| 138 | doxorubicin metabolic process (GO:0044598) | 3.10650156 |
| 139 | daunorubicin metabolic process (GO:0044597) | 3.10650156 |
| 140 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.10599726 |
| 141 | Golgi transport vesicle coating (GO:0048200) | 3.08605213 |
| 142 | COPI coating of Golgi vesicle (GO:0048205) | 3.08605213 |
| 143 | phenylpropanoid metabolic process (GO:0009698) | 3.07240711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.80550189 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.10532625 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.13019245 |
| 4 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.98936367 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.59498372 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.06853048 |
| 7 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.38301800 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.09723342 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.31916279 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.20890466 |
| 11 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.63485445 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.62187725 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.17972460 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.08643911 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.07202159 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.82752668 |
| 17 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.81702592 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70395385 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.66836432 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58980093 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.52992325 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.52954648 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.51126917 |
| 24 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.46867811 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45996244 |
| 26 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.45060849 |
| 27 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.44488644 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.43779794 |
| 29 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.42655615 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.41250024 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.40547535 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38328519 |
| 33 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37794832 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37427318 |
| 35 | P68_20966046_ChIP-Seq_HELA_Human | 1.36547485 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31748326 |
| 37 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30748195 |
| 38 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30290935 |
| 39 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29399285 |
| 40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28807978 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.27317684 |
| 42 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27098209 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26683677 |
| 44 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24625067 |
| 45 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.20116895 |
| 46 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19928358 |
| 47 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19766883 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.19711956 |
| 49 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18655247 |
| 50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17726995 |
| 51 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16717868 |
| 52 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.16648773 |
| 53 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.15984293 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15558481 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15221059 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14880214 |
| 57 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13766442 |
| 58 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12532415 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11420782 |
| 60 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07933215 |
| 61 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07628168 |
| 62 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.07437230 |
| 63 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05583064 |
| 64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05214014 |
| 65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04753528 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04558793 |
| 67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04028551 |
| 68 | MYC_22102868_ChIP-Seq_BL_Human | 1.03881185 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03216575 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02079981 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00314194 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97411893 |
| 73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96405272 |
| 74 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.96322069 |
| 75 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95494048 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95295827 |
| 77 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.94890913 |
| 78 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.93777596 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93171408 |
| 80 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92943654 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92804351 |
| 82 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.91190503 |
| 83 | * ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91110730 |
| 84 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91088826 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90834367 |
| 86 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90747365 |
| 87 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.90690429 |
| 88 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90575519 |
| 89 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89394725 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87351135 |
| 91 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87287309 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86065864 |
| 93 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85971200 |
| 94 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84480631 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81958340 |
| 96 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.79781251 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.79404564 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78909958 |
| 99 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78013179 |
| 100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77970905 |
| 101 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.75388483 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74702543 |
| 103 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74702543 |
| 104 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73947416 |
| 105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73410848 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.73129018 |
| 107 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.71990493 |
| 108 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71980617 |
| 109 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.71557821 |
| 110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.71388219 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70761298 |
| 112 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.70126722 |
| 113 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.70083570 |
| 114 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.69966995 |
| 115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69791261 |
| 116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69713178 |
| 117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.69080672 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68269499 |
| 119 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67950150 |
| 120 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67694993 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67399497 |
| 122 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.66902080 |
| 123 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.66028455 |
| 124 | ATF3_27146783_Chip-Seq_COLON_Human | 0.65370962 |
| 125 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64539551 |
| 126 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64492748 |
| 127 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.63308651 |
| 128 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.63145362 |
| 129 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.63137059 |
| 130 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62615115 |
| 131 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.60796598 |
| 132 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.59661588 |
| 133 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59269306 |
| 134 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.59021838 |
| 135 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.59014563 |
| 136 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.59014563 |
| 137 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.58915452 |
| 138 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58474323 |
| 139 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.58265295 |
| 140 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.57629817 |
| 141 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57354716 |
| 142 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.57048807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.34724644 |
| 2 | MP0005360_urolithiasis | 6.45314898 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.16584727 |
| 4 | * MP0005365_abnormal_bile_salt | 5.06618307 |
| 5 | * MP0008875_abnormal_xenobiotic_pharmacok | 4.97798773 |
| 6 | MP0009840_abnormal_foam_cell | 3.60958011 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.53324031 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.38481915 |
| 9 | MP0003252_abnormal_bile_duct | 3.19031210 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.93035954 |
| 11 | MP0005083_abnormal_biliary_tract | 2.80852579 |
| 12 | MP0005332_abnormal_amino_acid | 2.71189961 |
| 13 | MP0003195_calcinosis | 2.54883610 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.38984751 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.27004815 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.16940355 |
| 17 | MP0000609_abnormal_liver_physiology | 2.14860234 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.01047521 |
| 19 | MP0005670_abnormal_white_adipose | 1.95485614 |
| 20 | * MP0005319_abnormal_enzyme/_coenzyme | 1.82220726 |
| 21 | MP0003186_abnormal_redox_activity | 1.79035985 |
| 22 | MP0000566_synostosis | 1.78922304 |
| 23 | MP0008260_abnormal_autophagy | 1.72980787 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.65007230 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.63367713 |
| 26 | MP0005076_abnormal_cell_differentiation | 1.51749731 |
| 27 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.47236514 |
| 28 | MP0001764_abnormal_homeostasis | 1.44869580 |
| 29 | MP0002089_abnormal_postnatal_growth/wei | 1.44321313 |
| 30 | MP0004858_abnormal_nervous_system | 1.42126291 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.41556482 |
| 32 | MP0003868_abnormal_feces_composition | 1.32275811 |
| 33 | MP0002132_abnormal_respiratory_system | 1.32170991 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.30351688 |
| 35 | MP0003122_maternal_imprinting | 1.28288933 |
| 36 | MP0000604_amyloidosis | 1.26114586 |
| 37 | MP0002254_reproductive_system_inflammat | 1.25292545 |
| 38 | MP0004130_abnormal_muscle_cell | 1.23056055 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.22818880 |
| 40 | MP0009764_decreased_sensitivity_to | 1.19302602 |
| 41 | MP0005409_darkened_coat_color | 1.18728186 |
| 42 | MP0003011_delayed_dark_adaptation | 1.18335608 |
| 43 | * MP0000598_abnormal_liver_morphology | 1.17191279 |
| 44 | MP0005666_abnormal_adipose_tissue | 1.17020383 |
| 45 | MP0004272_abnormal_basement_membrane | 1.15594118 |
| 46 | MP0005451_abnormal_body_composition | 1.12831116 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 1.10833451 |
| 48 | MP0001849_ear_inflammation | 1.07407029 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.06637306 |
| 50 | MP0010368_abnormal_lymphatic_system | 1.06018140 |
| 51 | MP0002971_abnormal_brown_adipose | 1.01431143 |
| 52 | MP0001756_abnormal_urination | 1.00669569 |
| 53 | * MP0008469_abnormal_protein_level | 0.99993910 |
| 54 | MP0009763_increased_sensitivity_to | 0.99604888 |
| 55 | MP0005257_abnormal_intraocular_pressure | 0.99133732 |
| 56 | MP0000681_abnormal_thyroid_gland | 0.97947260 |
| 57 | MP0003300_gastrointestinal_ulcer | 0.97940501 |
| 58 | MP0000858_altered_metastatic_potential | 0.97439343 |
| 59 | * MP0001915_intracranial_hemorrhage | 0.97434569 |
| 60 | MP0005334_abnormal_fat_pad | 0.97217441 |
| 61 | MP0003123_paternal_imprinting | 0.97178920 |
| 62 | MP0000678_abnormal_parathyroid_gland | 0.96966604 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.96887220 |
| 64 | MP0002249_abnormal_larynx_morphology | 0.93728779 |
| 65 | MP0003690_abnormal_glial_cell | 0.93724899 |
| 66 | MP0009642_abnormal_blood_homeostasis | 0.93284619 |
| 67 | MP0003724_increased_susceptibility_to | 0.90929109 |
| 68 | MP0003879_abnormal_hair_cell | 0.90563389 |
| 69 | MP0002796_impaired_skin_barrier | 0.90184646 |
| 70 | MP0003436_decreased_susceptibility_to | 0.87730929 |
| 71 | MP0000003_abnormal_adipose_tissue | 0.86300444 |
| 72 | * MP0003566_abnormal_cell_adhesion | 0.83553358 |
| 73 | MP0004782_abnormal_surfactant_physiolog | 0.82666842 |
| 74 | MP0005464_abnormal_platelet_physiology | 0.82425100 |
| 75 | MP0002136_abnormal_kidney_physiology | 0.82009791 |
| 76 | MP0005535_abnormal_body_temperature | 0.80514716 |
| 77 | MP0003075_altered_response_to | 0.80342595 |
| 78 | MP0005376_homeostasis/metabolism_phenot | 0.79516821 |
| 79 | MP0005647_abnormal_sex_gland | 0.76228244 |
| 80 | MP0009697_abnormal_copulation | 0.75580456 |
| 81 | MP0003329_amyloid_beta_deposits | 0.75555040 |
| 82 | MP0004233_abnormal_muscle_weight | 0.73973859 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.73539175 |
| 84 | MP0009115_abnormal_fat_cell | 0.73408636 |
| 85 | MP0005084_abnormal_gallbladder_morpholo | 0.72985745 |
| 86 | MP0005220_abnormal_exocrine_pancreas | 0.72815740 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.72407812 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.72180438 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 0.71527676 |
| 90 | MP0005375_adipose_tissue_phenotype | 0.69366559 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 0.68452068 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.68142568 |
| 93 | MP0005448_abnormal_energy_balance | 0.67967016 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.66932435 |
| 95 | MP0003878_abnormal_ear_physiology | 0.65647801 |
| 96 | MP0005377_hearing/vestibular/ear_phenot | 0.65647801 |
| 97 | MP0002837_dystrophic_cardiac_calcinosis | 0.65133059 |
| 98 | MP0004043_abnormal_pH_regulation | 0.62109766 |
| 99 | MP0009672_abnormal_birth_weight | 0.61294625 |
| 100 | MP0005501_abnormal_skin_physiology | 0.60604519 |
| 101 | MP0003638_abnormal_response/metabolism_ | 0.59774600 |
| 102 | MP0002970_abnormal_white_adipose | 0.58721805 |
| 103 | MP0005164_abnormal_response_to | 0.58711033 |
| 104 | MP0001661_extended_life_span | 0.58236557 |
| 105 | MP0000249_abnormal_blood_vessel | 0.57326547 |
| 106 | MP0001853_heart_inflammation | 0.56435782 |
| 107 | MP0005266_abnormal_metabolism | 0.55998947 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 0.55754218 |
| 109 | MP0002098_abnormal_vibrissa_morphology | 0.55260750 |
| 110 | MP0003953_abnormal_hormone_level | 0.53674355 |
| 111 | MP0005166_decreased_susceptibility_to | 0.53205117 |
| 112 | MP0001765_abnormal_ion_homeostasis | 0.53153066 |
| 113 | MP0005408_hypopigmentation | 0.52933524 |
| 114 | MP0003941_abnormal_skin_development | 0.52106505 |
| 115 | MP0002909_abnormal_adrenal_gland | 0.51561490 |
| 116 | MP0003303_peritoneal_inflammation | 0.51447214 |
| 117 | MP0005023_abnormal_wound_healing | 0.51403795 |
| 118 | MP0002168_other_aberrant_phenotype | 0.51272152 |
| 119 | MP0002928_abnormal_bile_duct | 0.51056753 |
| 120 | MP0001845_abnormal_inflammatory_respons | 0.50301816 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.50155515 |
| 122 | MP0008438_abnormal_cutaneous_collagen | 0.50044001 |
| 123 | MP0000467_abnormal_esophagus_morphology | 0.49202221 |
| 124 | MP0009333_abnormal_splenocyte_physiolog | 0.49163356 |
| 125 | MP0004264_abnormal_extraembryonic_tissu | 0.48996362 |
| 126 | MP0001533_abnormal_skeleton_physiology | 0.48827605 |
| 127 | MP0009053_abnormal_anal_canal | 0.48255115 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.47575943 |
| 129 | MP0008961_abnormal_basal_metabolism | 0.46826495 |
| 130 | MP0004947_skin_inflammation | 0.46515305 |
| 131 | MP0008873_increased_physiological_sensi | 0.46460774 |
| 132 | MP0001881_abnormal_mammary_gland | 0.45496078 |
| 133 | MP0000343_altered_response_to | 0.45440085 |
| 134 | MP0000639_abnormal_adrenal_gland | 0.45052034 |
| 135 | MP0002060_abnormal_skin_morphology | 0.44686758 |
| 136 | MP0001944_abnormal_pancreas_morphology | 0.44683216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.30708040 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.10326418 |
| 3 | Xanthomatosis (HP:0000991) | 5.79305075 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 5.66901911 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.64779966 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 5.00861586 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.97563825 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.88003488 |
| 9 | Complement deficiency (HP:0004431) | 4.44320942 |
| 10 | Ketosis (HP:0001946) | 4.33395941 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.31055734 |
| 12 | Hyperglycinuria (HP:0003108) | 4.22313667 |
| 13 | Hyperammonemia (HP:0001987) | 4.20613420 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.15424185 |
| 15 | Hypoglycemic coma (HP:0001325) | 4.06335531 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.01101753 |
| 17 | Joint hemorrhage (HP:0005261) | 4.00504413 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.91482615 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 3.86236665 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.86236665 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.83957557 |
| 22 | Epidermoid cyst (HP:0200040) | 3.77502079 |
| 23 | Ketoacidosis (HP:0001993) | 3.65720003 |
| 24 | Hyperglycinemia (HP:0002154) | 3.61508183 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.58623283 |
| 26 | Hypercholesterolemia (HP:0003124) | 3.54914619 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.49467741 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.48527578 |
| 29 | Fat malabsorption (HP:0002630) | 3.37441807 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32999348 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.29550276 |
| 32 | Abnormality of complement system (HP:0005339) | 3.29187595 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 3.24106522 |
| 34 | Gout (HP:0001997) | 3.17943900 |
| 35 | Abnormality of purine metabolism (HP:0004352) | 3.16829384 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.05567120 |
| 37 | Myocardial infarction (HP:0001658) | 2.98852932 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 2.94589306 |
| 39 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.83042591 |
| 40 | Hyperbilirubinemia (HP:0002904) | 2.80463225 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 2.75874920 |
| 42 | Abnormality of the Achilles tendon (HP:0005109) | 2.71199428 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.69418454 |
| 44 | Abnormality of proline metabolism (HP:0010907) | 2.69413703 |
| 45 | Hydroxyprolinuria (HP:0003080) | 2.69413703 |
| 46 | Metabolic acidosis (HP:0001942) | 2.67776673 |
| 47 | Amyloidosis (HP:0011034) | 2.67499897 |
| 48 | Delayed CNS myelination (HP:0002188) | 2.67104220 |
| 49 | Purpura (HP:0000979) | 2.66799553 |
| 50 | Hypoglycemic seizures (HP:0002173) | 2.64513892 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.64102881 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64102881 |
| 53 | Skin nodule (HP:0200036) | 2.60156937 |
| 54 | Vertebral compression fractures (HP:0002953) | 2.57675022 |
| 55 | Late onset (HP:0003584) | 2.57168261 |
| 56 | Steatorrhea (HP:0002570) | 2.54796148 |
| 57 | Generalized aminoaciduria (HP:0002909) | 2.50805241 |
| 58 | Esophageal varix (HP:0002040) | 2.48769762 |
| 59 | Flat acetabular roof (HP:0003180) | 2.45150021 |
| 60 | Vascular calcification (HP:0004934) | 2.41682192 |
| 61 | Abnormality of serum amino acid levels (HP:0003112) | 2.39711710 |
| 62 | Abnormality of carpal bone ossification (HP:0006257) | 2.39473940 |
| 63 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38440359 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38440359 |
| 65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38440359 |
| 66 | Rickets (HP:0002748) | 2.33031388 |
| 67 | Spastic diplegia (HP:0001264) | 2.32505679 |
| 68 | Lethargy (HP:0001254) | 2.31917917 |
| 69 | Irritability (HP:0000737) | 2.29945627 |
| 70 | Glomerulonephritis (HP:0000099) | 2.24217483 |
| 71 | Pancreatitis (HP:0001733) | 2.22916964 |
| 72 | Sensorimotor neuropathy (HP:0007141) | 2.22733990 |
| 73 | Increased purine levels (HP:0004368) | 2.21764766 |
| 74 | Hyperuricemia (HP:0002149) | 2.21764766 |
| 75 | Spontaneous abortion (HP:0005268) | 2.20382973 |
| 76 | Hypertriglyceridemia (HP:0002155) | 2.19472677 |
| 77 | Menorrhagia (HP:0000132) | 2.18847097 |
| 78 | Cardiovascular calcification (HP:0011915) | 2.18319599 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16291293 |
| 80 | Malnutrition (HP:0004395) | 2.15644962 |
| 81 | Mitral stenosis (HP:0001718) | 2.14068313 |
| 82 | Hemorrhage of the eye (HP:0011885) | 2.10015168 |
| 83 | Abnormal gallbladder physiology (HP:0012438) | 2.09934105 |
| 84 | Cholecystitis (HP:0001082) | 2.09934105 |
| 85 | Brushfield spots (HP:0001088) | 2.09933605 |
| 86 | Polycythemia (HP:0001901) | 2.09517178 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09170124 |
| 88 | Abnormal cartilage morphology (HP:0002763) | 2.08709212 |
| 89 | Vomiting (HP:0002013) | 2.07765274 |
| 90 | Dysostosis multiplex (HP:0000943) | 2.05212651 |
| 91 | Neonatal onset (HP:0003623) | 2.03661026 |
| 92 | Abnormal gallbladder morphology (HP:0012437) | 2.03483939 |
| 93 | Proximal tubulopathy (HP:0000114) | 2.02680728 |
| 94 | Achilles tendon contracture (HP:0001771) | 2.02432523 |
| 95 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02386267 |
| 96 | Back pain (HP:0003418) | 2.02365416 |
| 97 | Gingival bleeding (HP:0000225) | 2.01717229 |
| 98 | Elevated alkaline phosphatase (HP:0003155) | 1.99574455 |
| 99 | Alkalosis (HP:0001948) | 1.99461139 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 1.99394333 |
| 101 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.98650005 |
| 102 | Cholelithiasis (HP:0001081) | 1.98283855 |
| 103 | Reticulocytosis (HP:0001923) | 1.96901233 |
| 104 | Neurofibrillary tangles (HP:0002185) | 1.96519211 |
| 105 | Abnormality of glycolysis (HP:0004366) | 1.94833906 |
| 106 | Mucopolysacchariduria (HP:0008155) | 1.94661778 |
| 107 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.94661778 |
| 108 | Abnormal tarsal ossification (HP:0008369) | 1.94031901 |
| 109 | Acanthocytosis (HP:0001927) | 1.93785153 |
| 110 | Hyperglycemia (HP:0003074) | 1.92547039 |
| 111 | Pathologic fracture (HP:0002756) | 1.91131244 |
| 112 | Protrusio acetabuli (HP:0003179) | 1.91089520 |
| 113 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.91002002 |
| 114 | Osteomalacia (HP:0002749) | 1.90104813 |
| 115 | Abnormal ossification of hand bones (HP:0005921) | 1.88053185 |
| 116 | Distal upper limb amyotrophy (HP:0007149) | 1.87558660 |
| 117 | Upper limb amyotrophy (HP:0009129) | 1.87558660 |
| 118 | Vacuolated lymphocytes (HP:0001922) | 1.87386543 |
| 119 | Nephritis (HP:0000123) | 1.86811791 |
| 120 | Increased serum pyruvate (HP:0003542) | 1.86663330 |
| 121 | Increased serum ferritin (HP:0003281) | 1.85795080 |
| 122 | Symptomatic seizures (HP:0011145) | 1.83229215 |
| 123 | Thrombophlebitis (HP:0004418) | 1.83029372 |
| 124 | Nausea (HP:0002018) | 1.82239968 |
| 125 | Enlarged kidneys (HP:0000105) | 1.81486223 |
| 126 | Opisthotonus (HP:0002179) | 1.81134010 |
| 127 | Cerebral inclusion bodies (HP:0100314) | 1.79403244 |
| 128 | Small epiphyses (HP:0010585) | 1.77898606 |
| 129 | Abnormality of glycolipid metabolism (HP:0010969) | 1.75501594 |
| 130 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.75501594 |
| 131 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.75501594 |
| 132 | Paraparesis (HP:0002385) | 1.74711511 |
| 133 | Widely patent fontanelles and sutures (HP:0004492) | 1.73035176 |
| 134 | Asymmetry of the thorax (HP:0001555) | 1.68978431 |
| 135 | Retinal atrophy (HP:0001105) | 1.67038456 |
| 136 | Cerebral aneurysm (HP:0004944) | 1.63839646 |
| 137 | Growth hormone excess (HP:0000845) | 1.59997033 |
| 138 | Loss of speech (HP:0002371) | 1.58786590 |
| 139 | Hand muscle atrophy (HP:0009130) | 1.58698765 |
| 140 | Hypophosphatemia (HP:0002148) | 1.57371257 |
| 141 | Abnormal hand bone ossification (HP:0010660) | 1.57124490 |
| 142 | Abdominal distention (HP:0003270) | 1.56167756 |
| 143 | Cervical subluxation (HP:0003308) | 1.54882456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.26764994 |
| 2 | ERN1 | 4.69370807 |
| 3 | TRIB3 | 3.93046321 |
| 4 | SIK1 | 3.76330367 |
| 5 | ICK | 3.58352648 |
| 6 | INSRR | 3.17038465 |
| 7 | FGFR4 | 3.15011796 |
| 8 | SMG1 | 2.82262895 |
| 9 | TAOK3 | 2.71725793 |
| 10 | MST1R | 2.49875273 |
| 11 | PKN2 | 2.45999344 |
| 12 | EEF2K | 2.28212282 |
| 13 | CDK12 | 2.15957184 |
| 14 | FLT3 | 1.99939290 |
| 15 | RIPK1 | 1.88276926 |
| 16 | PRPF4B | 1.87701852 |
| 17 | PTK6 | 1.83795689 |
| 18 | CAMK1D | 1.72664908 |
| 19 | EPHB1 | 1.66451450 |
| 20 | MAP3K3 | 1.53599128 |
| 21 | MAPK15 | 1.52072650 |
| 22 | EPHA2 | 1.51735231 |
| 23 | TGFBR2 | 1.49575955 |
| 24 | TBK1 | 1.49005821 |
| 25 | TESK1 | 1.47976922 |
| 26 | ERBB4 | 1.42188876 |
| 27 | MAP2K3 | 1.35727802 |
| 28 | FRK | 1.35606877 |
| 29 | TYK2 | 1.31434539 |
| 30 | DDR2 | 1.24701024 |
| 31 | TIE1 | 1.18823257 |
| 32 | PTK2 | 1.16406191 |
| 33 | TESK2 | 1.14898962 |
| 34 | GRK6 | 1.14649726 |
| 35 | MET | 1.14184527 |
| 36 | KDR | 1.14121081 |
| 37 | LATS2 | 1.10866518 |
| 38 | JAK2 | 1.07107367 |
| 39 | NME2 | 1.06822965 |
| 40 | CAMK1G | 1.06562758 |
| 41 | KIT | 1.05953410 |
| 42 | MAPK11 | 1.04948143 |
| 43 | ABL2 | 1.04011097 |
| 44 | LATS1 | 1.03360056 |
| 45 | IRAK3 | 1.02568482 |
| 46 | MAP3K2 | 1.02013698 |
| 47 | MAP3K11 | 0.98286765 |
| 48 | LRRK2 | 0.95527526 |
| 49 | MAP2K2 | 0.93958856 |
| 50 | PIK3CG | 0.93465119 |
| 51 | MAPKAPK3 | 0.92555427 |
| 52 | EPHA3 | 0.92536238 |
| 53 | CDC42BPA | 0.92335210 |
| 54 | NEK9 | 0.92228895 |
| 55 | PDK2 | 0.91367028 |
| 56 | ARAF | 0.88090442 |
| 57 | ZAP70 | 0.87336313 |
| 58 | TYRO3 | 0.87222936 |
| 59 | MAP2K1 | 0.87165859 |
| 60 | PIM2 | 0.86879920 |
| 61 | CSK | 0.86639387 |
| 62 | PDGFRA | 0.86442764 |
| 63 | MAP2K4 | 0.85031074 |
| 64 | JAK1 | 0.84018751 |
| 65 | MARK2 | 0.80810127 |
| 66 | MAP3K7 | 0.80496607 |
| 67 | PRKAA2 | 0.79407727 |
| 68 | BMX | 0.76916634 |
| 69 | DYRK1B | 0.76222964 |
| 70 | CDK7 | 0.73891361 |
| 71 | CDK6 | 0.72319706 |
| 72 | FER | 0.71030639 |
| 73 | GSK3A | 0.68963431 |
| 74 | JAK3 | 0.68549768 |
| 75 | MAP3K1 | 0.68468881 |
| 76 | MAP3K10 | 0.67625014 |
| 77 | MAPK4 | 0.65698296 |
| 78 | MAP3K6 | 0.65158127 |
| 79 | PDPK1 | 0.64772342 |
| 80 | ERBB2 | 0.63411710 |
| 81 | BTK | 0.63096842 |
| 82 | WNK4 | 0.62666032 |
| 83 | DAPK2 | 0.62520407 |
| 84 | RPS6KA2 | 0.61964467 |
| 85 | CSF1R | 0.60030464 |
| 86 | EPHB2 | 0.59956946 |
| 87 | LMTK2 | 0.58592464 |
| 88 | FGFR3 | 0.55023161 |
| 89 | MAP3K8 | 0.54779512 |
| 90 | PRKD2 | 0.54416991 |
| 91 | PAK4 | 0.53750091 |
| 92 | AKT2 | 0.53347668 |
| 93 | NTRK1 | 0.53310312 |
| 94 | IKBKE | 0.53114875 |
| 95 | PRKG2 | 0.53064751 |
| 96 | MAP3K14 | 0.52195533 |
| 97 | PINK1 | 0.50180606 |
| 98 | MAP4K1 | 0.49602687 |
| 99 | PRKACG | 0.49492793 |
| 100 | TTN | 0.47826292 |
| 101 | AKT3 | 0.46578495 |
| 102 | PRKCZ | 0.45829693 |
| 103 | IGF1R | 0.45209995 |
| 104 | FGR | 0.44820093 |
| 105 | RET | 0.43423617 |
| 106 | FGFR2 | 0.42888611 |
| 107 | SGK3 | 0.41227107 |
| 108 | EGFR | 0.38892010 |
| 109 | MTOR | 0.38281105 |
| 110 | CDK4 | 0.37850308 |
| 111 | TGFBR1 | 0.37775422 |
| 112 | WNK3 | 0.36727774 |
| 113 | NEK6 | 0.35977131 |
| 114 | RPS6KB2 | 0.35667593 |
| 115 | FGFR1 | 0.35053299 |
| 116 | MYLK | 0.34391233 |
| 117 | CDK9 | 0.33855882 |
| 118 | PAK3 | 0.33447242 |
| 119 | ABL1 | 0.33208713 |
| 120 | SIK2 | 0.32596745 |
| 121 | MAPK12 | 0.32511091 |
| 122 | SRC | 0.31571765 |
| 123 | PRKD1 | 0.31532930 |
| 124 | MATK | 0.31458256 |
| 125 | MAP2K6 | 0.30416322 |
| 126 | RPS6KL1 | 0.29950908 |
| 127 | RPS6KC1 | 0.29950908 |
| 128 | PRKAA1 | 0.29907012 |
| 129 | KSR2 | 0.29695494 |
| 130 | PDK4 | 0.29412258 |
| 131 | PDK3 | 0.29412258 |
| 132 | SCYL2 | 0.28202755 |
| 133 | STK38 | 0.28054627 |
| 134 | TAOK2 | 0.27896601 |
| 135 | CAMK2G | 0.27637409 |
| 136 | MAPKAPK2 | 0.27516408 |
| 137 | TAOK1 | 0.27235876 |
| 138 | PRKCH | 0.26666996 |
| 139 | CHUK | 0.26455410 |
| 140 | RPS6KA1 | 0.26006487 |
| 141 | PDK1 | 0.24957159 |
| 142 | PRKCI | 0.23867617 |
| 143 | LIMK1 | 0.23561869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.71701897 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.54661277 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.01084978 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68259270 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.67741309 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.64472292 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.60425724 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52731492 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49181717 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45861628 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.41428469 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.37584173 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.33955105 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.20092852 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.16205866 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.15885085 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.15078321 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12363091 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09989570 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07119877 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 2.03534229 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97420322 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87852179 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86298446 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76679232 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74531920 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.71308848 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65169290 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.64801386 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64460240 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50826925 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.50600207 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49971413 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.49290433 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44689984 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42321317 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35873946 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28879978 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27274790 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26726720 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26566818 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.25006348 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.22741294 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19744505 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18463413 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14165094 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12575220 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09186673 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08948212 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07296282 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05302108 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03026690 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97052907 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95356535 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92217999 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91834036 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90266978 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88698477 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85869781 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79459306 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79114986 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78130035 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.74820182 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74177402 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63417316 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55307705 |
| 67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54891316 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49938539 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49196591 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47804370 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.46012325 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42025146 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40161919 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40077444 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36791872 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.28850340 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27854381 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26145873 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.24494968 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18026646 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16048822 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13957703 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13540909 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13251167 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11241676 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.10647467 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.10366483 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.07839135 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.06104964 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05718544 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.05492303 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.05218378 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.04341476 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02560522 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1032330 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0993852 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | -0.0917713 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0733481 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0671108 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | -0.0506481 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0505997 |
| 102 | Pertussis_Homo sapiens_hsa05133 | -0.0462723 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | -0.0444675 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0373546 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0312307 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0292529 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | -0.0288802 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0183203 |

